Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
16 participants
INTERVENTIONAL
2022-01-01
2022-02-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Double-blind, Randomized, Parallel, Placebo-controlled Clinical Study to Evaluate the Viral Load of SARS-CoV-2 (COVID-19) in the Oral Cavity of SARS-CoV-2 Positive Subjects After the Use of a Mouthwash Containing Cetylpyridinium Chloride 0,07%.
NCT04757818
Antibacterial Effect and Substantivity of a New Chlorhexidine and Cymenol Gel on Oral Biofilm and Saliva
NCT06437262
A Comparison of Mouth Rinse Containing Alcohol-free Chlorhexidine With a Cetylpyridinium Chloride in Periodontal Diseases
NCT02756377
Clinical Effects of Two New Chlorhexidine Digluconate Formulations: 0.12% and 0.03%.
NCT02194023
Impact of a Newly Formulated Toothpaste in Tooth Staining Associated With Chlorhexidine Rinses
NCT05354986
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Such substantivity seems to require the adsorption of the agent on the buccal surfaces and subsequently exert a certain antimicrobial activity that seems to be mostly bacteriostatic.
Substantivity is the result of multiple factors controlling or altering adhesion, life period of antimicrobial capabilities, synergisms, antagonisms, and others. In order to improve substantivity and therefore increase antimicrobial effectiveness of CPC, o-Cymen-5-ol has recently been proposed to become incorporated to oral rinses. The aim of this work is to quantitatively determine the substantivity of (i) a single o-Cymen-5-ol plus CPC oral rinse, (ii) a, CPC oral rinse and (iii) a o-Cymen-5-ol mouthwash on the salivary microbiota up to 4 h after their application.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
placebo oral rinse
Placebo comparator Volume Time Active molecule 15 mL 1 min No
Oral rinse
Participants use mouthwasher for a given time.
Saliva harvest
Non-stimulated saliva harvesting
CPC oral rinse
Volume Time Active molecule 15 mL 1 min CPC containing oral rinse
Oral rinse
Participants use mouthwasher for a given time.
Saliva harvest
Non-stimulated saliva harvesting
Cymenol oral rinse
Volume Time Active molecule 15 mL 1 min Cymenol containing oral rinse
Oral rinse
Participants use mouthwasher for a given time.
Saliva harvest
Non-stimulated saliva harvesting
CPC + Cymenol oral rinse
Volume Time Active molecule 15 mL 1 min CPC+cymenol containing oral rinse
Oral rinse
Participants use mouthwasher for a given time.
Saliva harvest
Non-stimulated saliva harvesting
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oral rinse
Participants use mouthwasher for a given time.
Saliva harvest
Non-stimulated saliva harvesting
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. good oral helath status
3. minimum 24 evaluable teeth
4. periodontal pockets ≤3 mm
5. absence of caries \& periodontal haemorrage
Exclusion Criteria
2. prosthesis or orthodontic devices
3. Sjögren syndrome
4. Antibiotic treatment in the last three months
5. Systemic disease with alteration in the production and/or composition of the saliva
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Barcelona
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Miguel Viñas
Full professor Microbiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Miguel Viñas, PhD
Role: STUDY_CHAIR
University of Barcelona-Spain-
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Barcelona. Campus Bellvitge
L'Hospitalet de Llobregat, Barcelona, Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Aguilera FR, Vinas M, Sierra JM, Vinuesa T, R Fernandez de Henestrosa A, Furmanczyk M, Trullas C, Jourdan E, Lopez-Lopez J, Jorba M. Substantivity of mouth-rinse formulations containing cetylpyridinium chloride and O-cymen-5-ol: a randomized-crossover trial. BMC Oral Health. 2022 Dec 27;22(1):646. doi: 10.1186/s12903-022-02688-z.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
33/2021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.